{"id":"https://openalex.org/W4382631133","doi":"https://doi.org/10.1182/bloodadvances.2023010303","title":"Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia","display_name":"Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia","publication_year":2023,"publication_date":"2023-06-30","ids":{"openalex":"https://openalex.org/W4382631133","doi":"https://doi.org/10.1182/bloodadvances.2023010303","pmid":"https://pubmed.ncbi.nlm.nih.gov/37389830","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10784681"},"language":"en","primary_location":{"id":"doi:10.1182/bloodadvances.2023010303","doi":"https://doi.org/10.1182/bloodadvances.2023010303","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2023010303","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/doi/10.1182/bloodadvances.2023010303/2061399/bloodadvances.2023010303.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ashpublications.org/bloodadvances/article-pdf/doi/10.1182/bloodadvances.2023010303/2061399/bloodadvances.2023010303.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049059619","display_name":"Shai O. Shimony","orcid":"https://orcid.org/0000-0001-7245-9652","observed_orcids":["https://orcid.org/0000-0001-7245-9652"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2800389475","display_name":"Rabin Medical Center","ror":"https://ror.org/01vjtf564","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2800389475","https://openalex.org/I64767286"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["IL","US"],"is_corresponding":false,"raw_author_name":"Shai Shimony","raw_affiliation_strings":["1Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA","2Department of Hematology, Rabin Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel","Dana-Farber Cancer Institute, Boston, Massachusetts, United States"],"raw_orcid":"https://orcid.org/0000-0001-7245-9652","affiliations":[{"raw_affiliation_string":"1Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"2Department of Hematology, Rabin Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel","institution_ids":["https://openalex.org/I16391192","https://openalex.org/I2800389475"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, Massachusetts, United States","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082924494","display_name":"Daniel J. DeAngelo","orcid":"https://orcid.org/0000-0001-7865-2306","observed_orcids":["https://orcid.org/0000-0001-7865-2306"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J. DeAngelo","raw_affiliation_strings":["1Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA","Dana-Farber Cancer Institute, Boston, Massachusetts, United States"],"raw_orcid":"https://orcid.org/0000-0001-7865-2306","affiliations":[{"raw_affiliation_string":"1Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, Massachusetts, United States","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023296232","display_name":"Marlise Rachael Luskin","orcid":"https://orcid.org/0000-0002-5781-4529","observed_orcids":["https://orcid.org/0000-0002-5781-4529"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marlise R. Luskin","raw_affiliation_strings":["1Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA","Dana-Farber Cancer Institute, Boston, Massachusetts, United States"],"raw_orcid":"https://orcid.org/0000-0002-5781-4529","affiliations":[{"raw_affiliation_string":"1Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, Massachusetts, United States","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5023296232"],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":1.7796,"has_fulltext":true,"cited_by_count":39,"citation_normalized_percentile":{"value":0.85939121,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"8","issue":"1","first_page":"23","last_page":"36"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nelarabine","display_name":"nelarabine","score":1.0},{"id":"https://openalex.org/keywords/t-cell-acute-lymphoblastic-leukemia","display_name":"T-cell acute lymphoblastic leukemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/t-lymphoblastic-lymphoma","display_name":"T-cell lymphoblastic lymphoma","score":0.9330000281333923},{"id":"https://openalex.org/keywords/relapsed-refractory-leukemia","display_name":"relapsed/refractory leukemia","score":0.8370000123977661},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.8460000157356262},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8349999785423279}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.75848388671875},{"id":"https://openalex.org/C2777478502","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic lymphoma","level":4,"score":0.7429720759391785},{"id":"https://openalex.org/C113842279","wikidata":"https://www.wikidata.org/wiki/Q1873857","display_name":"Lymphoblast","level":3,"score":0.6755645871162415},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5401744842529297},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5389270782470703},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.4635692238807678},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4469616711139679},{"id":"https://openalex.org/C2781107101","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Acute lymphocytic leukemia","level":4,"score":0.4253455400466919},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4120384156703949},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.361549437046051},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3459588885307312},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3304463028907776},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2520354986190796},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.18843570351600647},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.07086712121963501},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06979575753211975},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.06815120577812195},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001087","descriptor_name":"Arabinonucleosides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016399","descriptor_name":"Lymphoma, T-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D054218","descriptor_name":"Precursor T-Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/bloodadvances.2023010303","doi":"https://doi.org/10.1182/bloodadvances.2023010303","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2023010303","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/doi/10.1182/bloodadvances.2023010303/2061399/bloodadvances.2023010303.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10784681","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10784681","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10784681/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},{"id":"pmid:37389830","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37389830","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood advances","raw_type":"Review"}],"best_oa_location":{"id":"doi:10.1182/bloodadvances.2023010303","doi":"https://doi.org/10.1182/bloodadvances.2023010303","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2023010303","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/doi/10.1182/bloodadvances.2023010303/2061399/bloodadvances.2023010303.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4382631133.pdf","grobid_xml":"https://content.openalex.org/works/W4382631133.grobid-xml"},"referenced_works_count":92,"referenced_works":["https://openalex.org/W1514289037","https://openalex.org/W1536252480","https://openalex.org/W1559637642","https://openalex.org/W1585375343","https://openalex.org/W1641010126","https://openalex.org/W1831821249","https://openalex.org/W1862517694","https://openalex.org/W1961663274","https://openalex.org/W1977380325","https://openalex.org/W1991343198","https://openalex.org/W2000589976","https://openalex.org/W2003307365","https://openalex.org/W2008271341","https://openalex.org/W2009069048","https://openalex.org/W2014613440","https://openalex.org/W2026450884","https://openalex.org/W2028238878","https://openalex.org/W2049443129","https://openalex.org/W2052739233","https://openalex.org/W2052846308","https://openalex.org/W2053908817","https://openalex.org/W2055482234","https://openalex.org/W2060605982","https://openalex.org/W2061585822","https://openalex.org/W2064276205","https://openalex.org/W2065077038","https://openalex.org/W2070688008","https://openalex.org/W2074464967","https://openalex.org/W2085453248","https://openalex.org/W2094546718","https://openalex.org/W2099867002","https://openalex.org/W2110056604","https://openalex.org/W2115482777","https://openalex.org/W2126136473","https://openalex.org/W2128491464","https://openalex.org/W2143364167","https://openalex.org/W2147996630","https://openalex.org/W2152588250","https://openalex.org/W2156377069","https://openalex.org/W2166306614","https://openalex.org/W2316423009","https://openalex.org/W2316493963","https://openalex.org/W2326217500","https://openalex.org/W2336673742","https://openalex.org/W2339658711","https://openalex.org/W2418819004","https://openalex.org/W2580322451","https://openalex.org/W2611177651","https://openalex.org/W2617763104","https://openalex.org/W2626936646","https://openalex.org/W2767124204","https://openalex.org/W2781552270","https://openalex.org/W2791923357","https://openalex.org/W2888141473","https://openalex.org/W2889648694","https://openalex.org/W2899881592","https://openalex.org/W2921167368","https://openalex.org/W2936779111","https://openalex.org/W2953350029","https://openalex.org/W2969862977","https://openalex.org/W2973839676","https://openalex.org/W2978348183","https://openalex.org/W2990689630","https://openalex.org/W3036817072","https://openalex.org/W3048707350","https://openalex.org/W3063038225","https://openalex.org/W3096671481","https://openalex.org/W3102538166","https://openalex.org/W3108211592","https://openalex.org/W3120316021","https://openalex.org/W3131213086","https://openalex.org/W3134387429","https://openalex.org/W3184408541","https://openalex.org/W3211670900","https://openalex.org/W3212135775","https://openalex.org/W4206029839","https://openalex.org/W4220832257","https://openalex.org/W4221105120","https://openalex.org/W4229024420","https://openalex.org/W4281906746","https://openalex.org/W4286296026","https://openalex.org/W4292566576","https://openalex.org/W4310107967","https://openalex.org/W4310108029","https://openalex.org/W4310112967","https://openalex.org/W4311201797","https://openalex.org/W4311679972","https://openalex.org/W4362635171","https://openalex.org/W4375852249","https://openalex.org/W6630721991","https://openalex.org/W6638939039","https://openalex.org/W6640702786"],"related_works":["https://openalex.org/W2036554388","https://openalex.org/W2556104576","https://openalex.org/W7160630115","https://openalex.org/W2061585822","https://openalex.org/W4387728813","https://openalex.org/W2016195040","https://openalex.org/W72702804","https://openalex.org/W3153510529","https://openalex.org/W7100572208","https://openalex.org/W159138647"],"abstract_inverted_index":{"ABSTRACT:":[0],"T-cell":[1],"acute":[2],"lymphoblastic":[3,6],"leukemia":[4],"or":[5,86],"lymphoma":[7],"(T-ALL/LBL)":[8],"is":[9,33,43,78,118],"a":[10,36,123],"rare":[11],"hematologic":[12],"malignancy":[13],"most":[14],"commonly":[15],"affecting":[16],"adolescent":[17],"and":[18,53,56,69,74,96,117,130,140],"young":[19],"adult":[20,131],"males.":[21],"Outcomes":[22],"are":[23],"dismal":[24],"for":[25,60,80,114],"patients":[26,83,153],"who":[27],"relapse,":[28],"thus,":[29],"improvement":[30],"in":[31,72,102,108,128,149],"treatment":[32,62,81,127,151],"needed.":[34],"Nelarabine,":[35],"prodrug":[37],"of":[38,63,82,125,147,152],"the":[39,61,90,145,150],"deoxyguanosine":[40],"analog":[41],"9-\u03b2-arabinofuranosylguanine,":[42],"uniquely":[44],"toxic":[45],"to":[46,144],"T":[47],"lymphoblasts,":[48],"compared":[49],"with":[50,84,89,110,154],"B":[51],"lymphoblasts":[52],"normal":[54],"lymphocytes,":[55],"has":[57,105],"been":[58,106],"developed":[59],"T-ALL/LBL.":[64,155],"Based":[65],"on":[66,138],"phase":[67],"1":[68],"2":[70],"trials":[71],"children":[73],"adults,":[75],"single-agent":[76],"nelarabine":[77,104,139,148],"approved":[79],"relapsed":[85,115],"refractory":[87],"T-ALL/LBL,":[88],"major":[91],"adverse":[92],"effect":[93],"being":[94,120],"central":[95],"peripheral":[97],"neurotoxicity.":[98],"Since":[99],"its":[100],"approval":[101],"2005,":[103],"studied":[107,121],"combination":[109],"other":[111],"chemotherapy":[112],"agents":[113],"disease":[116],"also":[119],"as":[122],"component":[124],"initial":[126],"pediatric":[129],"patients.":[132],"Here,":[133],"we":[134],"review":[135],"current":[136],"data":[137],"present":[141],"our":[142],"approach":[143],"use":[146]},"counts_by_year":[{"year":2026,"cited_by_count":15},{"year":2025,"cited_by_count":15},{"year":2024,"cited_by_count":9}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-07-01T00:00:00"}